Macrophage-elicited loss of estrogen receptor-α in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locus

Oncogene

Volumn 31, Issue 14, 2012, Pages 1825-1834

  Stossi, F ^a   Madak Erdogan Z ^a   Katzenellenbogen, B S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

breast cancer; estrogen receptor; jun; macrophages; MAPK

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN C JUN; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ARTICLE; BREAST CANCER; CHROMATIN; CONTROLLED STUDY; GENE ACTIVATION; GENE INDUCTION; GENE LOCUS; GENE LOSS; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT;

BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-JUN;

EID: 84860406451     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.370     Document Type: Article

References (49)

1. Allavena P, Sica A, Garlanda C, Mantovani A. (2008a). The Ying- Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 222: 155-161. (Pubitemid 351430369)
2. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. (2008b). The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 66: 1-9. (Pubitemid 351324128)
3. Auwerx J. (1991). The human leukemia cell line, THP-1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia 47: 22-31.
4. Bayliss J, Hilger A, Vishnu P, Diehl K, El-Ashry D. (2007). Reversal of estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response. Clin Cancer Res 13: 7029-7036. (Pubitemid 350276884)
5. Beck AH, Espinosa I, Edris B, Li R, Montgomery K, Zhu S et al. (2009). The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin Cancer Res 15: 778-787.
6. Benoit M, Desnues B, Mege JL. (2008). Macrophage polarization in bacterial infections. J Immunol 181: 3733-3739.
7. Brinkman JA, El-Ashry D. (2009). ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers. J Mammary Gland Biol Neoplasia 14: 67-78.
8. Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT et al. (2005). Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 23: 953-964. (Pubitemid 46202315)
9. Cheung KL, Willsher PC, Pinder SE, Ellis IO, Elston CW, Nicholson RI et al. (1997). Predictors of response to second-line endocrine therapy for breast cancer. Breast Cancer Res Treat 45: 219-224. (Pubitemid 27453790)
10. Chu I, Arnaout A, Loiseau S, Sun J, Seth A, McMahon C et al. (2007). Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer. J Clin Invest 117: 2205-2215. (Pubitemid 47219565)
11. Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D. (2006). Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cell in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Cancer Res 66: 3903-3911.
12. Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH. (2010). The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5: e8668.
13. Dumont JA, Bitonti AJ, Wallace CD, Baumann RJ, Cashman EA, Cross-Doersen DE. (1996). Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. Cell Growth Differ 7: 351-359. (Pubitemid 26360774)
14. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. (2009). Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
15. Johnston SR. (1997). Acquired tamoxifen resistance in human breast cancer - potential mechanisms and clinical implications. Anticancer Drugs 8: 911-930.
16. Johnston SR, Lu B, Scott GK, Kushner PJ, Smith IE, Dowsett M et al. (1999). Increased activator protein-1 DNA binding and c-Jun NH2- terminal kinase activity in human breast tumors with acquired tamoxifen resistance. Clin Cancer Res 5: 251-256. (Pubitemid 29085176)
17. Johnston SR, Saccani-Jotti G, Smith IE, Salter J, Newby J, Coppen M et al. (1995). Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res 55: 3331-3338.
18. Jordan VC, O'Malley BW. (2007). Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J Clin Oncol 25: 5815-5824.
19. Kos M, Reid G, Denger S, Gannon F. (2001). Minireview: genomic organization of human ERalpha gene promoter region. Mol Endocrinol 15: 2057-2063. (Pubitemid 33141126)
20. Lawrence MC, Shao C, McGlynn K, Naziruddin B, Levy MF, Cobb MH. (2009). Multiple chromatin-bound protein kinases assemble factors that regulate insulin gene transcription. Proc Natl Acad Sci USA 106: 22181-22186.
21. Leek RD, Landers RJ, Harris AL, Lewis CE. (1999). Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79: 991-995. (Pubitemid 29082138)
22. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. (1996). Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629. (Pubitemid 26338061)
23. Lewis CE, Pollard JW. (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605-612. (Pubitemid 43165918)
24. Ma J, Liu L, Che G, Yu N, Dai F, You Z. (2010). The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 10: 112.
25. Madak-Erdogan Z, Lupien M, Stossi F, Brown M, Katzenellenbogen BS. (2011). Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs. Mol Cell Biol 31: 226-236.
26. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686. (Pubitemid 39457982)
27. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. (2002). Macrophage polarization: tumor-associated macrophages as paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555. (Pubitemid 35223554)
28. Martinez FO, Gordon S, Locati M, Mantovani A. (2006). Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177: 7303-7311. (Pubitemid 44715100)
29. Martinez FO, Sica A, Mantovani A, Locati M. (2008). Macrophage activation and polarization. Front Biosci 13: 453-461. (Pubitemid 351599757)
30. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M et al. (2003). Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763. (Pubitemid 38030303)
31. Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van den Bossche J et al. (2010). Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6- C(high) monocytes. Cancer Res 70: 5728-5739.
32. Musgrove EA, Sutherland RL. (2009). Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9: 631-643.
33. Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D. (2001). Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells. Mol Endocrinol 15: 1344-1359. (Pubitemid 32703482)
34. Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. (2009). Macrophages within NSCLC tumor islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J 33: 118-126.
35. Pupa SM, Bufalino R, Invernizzi AM, Andreola S, Rilke F, Lombardi L et al. (1996). Macrophage infiltrate and prognosis in c-erbB-2 overexpressing breast carcinomas. J Clin Oncol 14: 85-94. (Pubitemid 26020000)
36. Qian BZ, Pollard JW. (2010). Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
37. Redente EF, Dwyer-Nield LD, Merrick DT, Raina K, Agarwal R, Pao W et al. (2010). Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization. Am J Pathol 176: 2972-2985.
38. Shabo I, Stal O, Olsson H, Dore S, Svanvik J. (2008). Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer 123: 780-786. (Pubitemid 352032402)
39. Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S et al. (2009). Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ. Breast Cancer Res Treat 123: 397-404.
40. Sica A, Allavena P, Mantovani A. (2008a). Cancer related inflammation: the macrophage conenction. Cancer Lett 267: 204-215.
41. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG et al. (2008b). Macrophage polarization in tumor progression. Semin Cancer Biol 18: 349-355.
42. Sica A, Schioppa T, Mantovani A, Allavena P. (2006). Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42: 717-727.
43. Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, Reddy P et al. (1999). cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18: 6063-6070. (Pubitemid 29535018)
44. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS. (2004). Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 145: 3473-3486. (Pubitemid 38830020)
45. Stossi F, Madak-Erdogan Z, Katzenellenbogen BS. (2009). Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1. Mol Cell Biol 29: 1749-1759.
46. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T et al. (1982). Induction of maturation in cultured human monocytic leukemia cells by phorbol diester. Cancer Res 42: 1530-1536. (Pubitemid 12148801)
47. Watkins SK, Egilmez NK, Suttles J, Stout RD. (2007). IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J Immunol 178: 1357-1362. (Pubitemid 46154605)
48. Yuan A, Chen JJ, Yang PC. (2008). Pathophysiology of tumor-associated macrophages. Adv Clin Chem 45: 199-223.
49. Zhu P, Baek SH, Bourk EM, Ohgi KA, Garcia-Bassets I, Sanjo H et al. (2006). Macrophage/cancer cell interactions mediate hormone resistance by nuclear receptor derepression pathway. Cell 124: 615-629. (Pubitemid 43199445)